Immunosafety is a dynamic and interdisciplinary field that incorporates the evaluation of how new drugs, therapies, vaccines, food additives, cosmetics, and a variety of chemicals affect the immune system and to determine the relative “safety" of these entities in people, animals, and within the environment.
The primary objective of this training course is to promote a greater understanding and use of immunosafety information in both the scientific community and society at large. The Cancer Immunotherapies module designed to provide the foundational biology while highlighting and describing therapeutic approaches across various modalities and discussing related safety issues. All lectures contained within this module are 45-60 minutes in duration. While having some knowledge of basic cancer immunology is helpful, it is not required.
Participants will have the flexibility to select topics based on interest and or need and can work towards obtaining a certificate of completion for completing course and quizzes contain in this module .
This course is intended to serve as resource for those who are interested in learning about cancer immunotherapies and/or looking for professional development opportunities in the form of continuing education and networking.
This course intended for the science professional or graduate student looking learn fundamental science and key consideration that are examined in immune safety assessment. Advance topics and coursed that take a deeper dive into specific scientific areas will be offer and is recommend for the more experienced scientist who has a firm grasp on the information highlighted in the introduction module.
Each lecture within this module will have learning objectives specific to the topics covered. You can see a complete list of the topics covered in this module under the program tab.
After the successful completion of assessment questions, participants will receive a certificate of completion.
- 9.00 Participation